Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Irreversible electroporation (IRE) for treatment of locally advanced pancreatic tumors is garnering increasing attention. This study was conducted to determine perioperative morbidity and mortality for locally advanced pancreatic cancer.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann. Surg. Oncol.

Title: Annals of surgical oncology

Publisher: Springer Nature

ISSN (Electronic): 1534-4681

ISSN (Print): 1068-9265

Publication date (Electronic): May 2016

Volume: 23

Issue: 5

Affiliations

[1 ] Division of Gastrointestinal & Endocrine Surgery, Department of Surgery, New York-Presbyterian Hospital, Columbia University, College of Physicians and Surgeons, New York, NY, USA. mk2462@columbia.edu.

[2 ] Division of Gastrointestinal & Endocrine Surgery, Department of Surgery, New York-Presbyterian Hospital, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

[3 ] Division of Abdominal Imaging, Department of Radiology, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

[4 ] Division of Vascular and Interventional Radiology, Department of Radiology, Columbia University, College of Physicians and Surgeons, New York, NY, USA.

Article

Publisher Item ID: 10.1245/s10434-015-5034-x

DOI: 10.1245/s10434-015-5034-x

PubMed ID: 26714959

SO-VID: b992dc88-2600-4b0b-af24-484fe731ea11

History

Data availability:

Comments

Comment on this article

scite_

Cited by 36

See all cited by